Skip to main content

For the third year, Mark Few is one of 48 of the nation’s top NCAA Division I Men’s Basketball coaches participating in ESPN’s Coaches’ Charity Challenge. Competing coaches count on their fans for votes to advance in the tournament-like competition. 

The coaches receiving the most votes advance to the next round every three weeks and the top vote-getters will eventually gain a spot in the finals. The winning coach will receive $100,000 toward his charity of choice.

“This community and the fight against cancer have been very important to me and Marcy for years,” explains Coach Few. “By participating in this national challenge, I saw a great opportunity to partner with Community Cancer Fund and raise money for local cancer patients and their families.”

Few is the only coach in the Inland Northwest participating in this year’s Coaches Challenge. For the past two years, he’s advanced to the second round, totaling $15,000 in donations to local cancer patients via his charity of choice, Community Cancer Fund. But if you know anything about Mark Few, you know he likes to win and is urging his supporters to vote daily.

“I’m asking everyone to take a small amount of time every day to help make a difference in the lives of local cancer patients.”

With the Challenge starting this past Monday, Few is currently ranked #23 in the standings. The first round of voting ends Jan. 22 with the Top 24 coaches garnering votes advancing. The second round runs through Feb. 12. The third round ends Feb. 26 and the final round runs Feb. 27 – March 12.

Participants can learn more and vote daily at VoteCoachFew.com.

About Community Cancer Fund

The Community Cancer Fund is dedicated to fighting cancer in the Inland Northwest by funding local cancer prevention and screening programs, supporting cancer patients and their families at every stage of their illness and recovery and funding groundbreaking local research. All donations made to Community Cancer Fund are invested in local programs to benefit local cancer patients.